COGT

$31.491.38%0.43

After Hours: 31.65+0.16 +0.51%

Cogent Biosciences Inc (COGT)

Cogent Biosciences Inc Stock (COGT) Forecast

The Cogent Biosciences Inc (COGT) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $29.90, representing a -5.06% decrease from the current price of $31.49. The highest analyst price target is $30.89, and the lowest is $28.91.

Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.

12-Month COGT Price Target

Average 37.54 (+19.21% Downside)

Is Cogent Biosciences Inc (COGT) A Buy Now?

Oscillators

Name	Value	Action
RSI(14)	51.25	Neutral
STOCH(9,6)	49.64	Neutral
STOCHRSI(14)	73.45	Neutral
MACD(12,26)	-0.19	Buy
ADX(14)	19.31	Neutral
William %R	-33.50	Neutral
CCI(14)	7.67	Neutral

Buy: 1 · Sell: 0 · Neutral: 6Summary: Neutral

Moving Averages

Period	Simple	Exponential
MA10	31.29 Buy	31.08 Buy
MA20	30.59 Buy	31.08 Buy
MA50	32.08 Sell	32.28 Sell
MA100	35.28 Sell	33.60 Sell
MA200	35.58 Sell	32.26 Sell

Buy: 4 · Sell: 6 · Neutral: 0Summary: Sell

According to our latest analysis, COGT could be considered a Neutral, with 17 technical analysis indicators signaling 5 Buy signals, 6 signaling Sell signals and 6 Neutral signals. This suggests that investors should exercise caution when entering new positions on COGT, as the market is likely to remain volatile in the near term.

RSI (Relative Strength Index): The RSI(14) value of 51.25 indicates that COGT is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
STOCH (Stochastic Oscillator): The STOCH value of 49.64 indicates that COGT is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 73.45 indicates that COGT is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
ADX (Average Directional Index): The ADX value of 19.31 suggests that there may be some movement in price, but it lacks strength or conviction.
CCI (Commodity Channel Index): A CCI(14) value of 7.67 indicates that COGT is not in oversold or overbought territory. It suggests a neutral sentiment in the short term.

Long-term COGT price forecast for 2026, 2030, 2035, 2040, 2045 and 2050

Based on our analysis about Cogent Biosciences Inc financial reports and earnings history, Cogent Biosciences Inc (COGT) stock could reach $59.44 by 2030, $133.84 by 2040 and $174.64 by 2050. See the projected annual prices until 2050 of the Cogent Biosciences Inc stock below:

Cogent Biosciences Inc (COGT) is expected to reach an average price of $102.64 in 2035, with a high prediction of $104.82 and a low estimate of $83.49. This indicates an +225.96% change from the last recorded price of $31.49.
Cogent Biosciences Inc (COGT) stock is projected to chart a bullish course in 2040, with an average price target of $133.65, representing an +324.43% change from its current level. The forecast ranges from a conservative $115.77 to a sky-high $133.84.
Our analysts predict Cogent Biosciences Inc (COGT) to change +402.80% by 2045, soaring from $129.84 to an average price of $158.33, potentially reaching $159.21. While $129.84 is the low estimate, the potential upside is significant.
Cogent Biosciences Inc (COGT) stock is expected to climb by 2050, reaching an average of $174.62, a +454.54% change from its current level. However, a wide range of estimates exists, with high and low targets of $174.64 and $130.08, respectively, highlighting the market's uncertainty.

Cogent Biosciences Inc Stock (COGT) Year by Year Forecast

Cogent Biosciences Inc Stock (COGT) Price Forecast for 2026

The predicted value for Cogent Biosciences Inc (COGT) in 2026 is set at an average of $34.98. Estimates vary from a peak of $43.39 to a trough of $27.74, indicating an +11.07% surge from the present price of $31.49.

Month	Average	Low	High	Change from today's price
December, 2026	$30.71	$28.91	$30.89	-2.49%

Cogent Biosciences Inc Stock (COGT) Price Forecast for 2027

For 2027, Stockscan's Analyst expects the average price target for Cogent Biosciences Inc (COGT) is $35.70, with a high forecast of $46.17 and a low forecast of $28.99. This indicates an +13.38% increase from the last price of $31.49.

Month	Average	Low	High	Change from today's price
January, 2027	$30.20	$29.80	$31.19	-4.08%
February, 2027	$29.78	$29.20	$30.78	-5.42%
March, 2027	$29.64	$28.99	$30.22	-5.86%
April, 2027	$32.32	$29.13	$32.34	+2.65%
May, 2027	$31.63	$31.00	$33.69	+0.46%
June, 2027	$30.29	$29.05	$31.68	-3.80%
July, 2027	$35.55	$29.96	$36.86	+12.90%
August, 2027	$37.88	$35.05	$39.04	+20.30%
September, 2027	$42.65	$37.34	$44.68	+35.45%
October, 2027	$44.48	$42.44	$46.17	+41.26%
November, 2027	$42.42	$41.38	$45.78	+34.72%
December, 2027	$41.54	$41.04	$43.75	+31.92%

Cogent Biosciences Inc Stock (COGT) Price Forecast for 2028

In 2028, Cogent Biosciences Inc (COGT) is projected to reach an average price of $45.39, with a high projection of $49.72 and a low estimate of $40.25. This indicates an +44.14% rise from the last price of $31.49.

Month	Average	Low	High	Change from today's price
January, 2028	$43.00	$40.25	$43.09	+36.56%
February, 2028	$42.22	$40.98	$43.58	+34.08%
March, 2028	$45.66	$41.73	$46.33	+45.00%
April, 2028	$45.44	$44.59	$47.20	+44.30%
May, 2028	$43.97	$43.63	$45.88	+39.64%
June, 2028	$43.35	$42.30	$44.30	+37.66%
July, 2028	$45.00	$43.56	$46.27	+42.91%
August, 2028	$46.38	$44.83	$47.72	+47.29%
September, 2028	$47.29	$46.20	$48.00	+50.17%
October, 2028	$47.15	$47.00	$49.00	+49.73%
November, 2028	$48.42	$46.15	$48.62	+53.76%
December, 2028	$46.80	$46.48	$49.72	+48.61%

Cogent Biosciences Inc Stock (COGT) Price Forecast for 2029

The 2029 price forecast for Cogent Biosciences Inc Stock (COGT) is $48.24 on average, with a high prediction of $54.11 and a low estimate of $42.44. This represents an +53.19% increase from the previous price of $31.49.

Month	Average	Low	High	Change from today's price
January, 2029	$45.72	$45.70	$47.33	+45.19%
February, 2029	$46.04	$44.54	$46.74	+46.20%
March, 2029	$47.27	$44.63	$48.18	+50.10%
April, 2029	$44.40	$42.44	$45.91	+40.99%
May, 2029	$44.71	$43.92	$44.76	+41.97%
June, 2029	$47.48	$44.67	$50.59	+50.77%
July, 2029	$47.91	$46.92	$48.28	+52.14%
August, 2029	$47.78	$47.60	$49.16	+51.72%
September, 2029	$49.77	$48.00	$50.24	+58.04%
October, 2029	$51.83	$49.55	$52.18	+64.58%
November, 2029	$52.22	$51.02	$53.17	+65.82%
December, 2029	$53.78	$52.16	$54.11	+70.77%

Cogent Biosciences Inc Stock (COGT) Price Forecast for 2030

Cogent Biosciences Inc Stock (COGT) is expected to reach an average price of $56.35 in 2030, with a high forecast of $59.44 and a low forecast of $53.44. This signifies an +78.96% surge from the last price of $31.49.

Month	Average	Low	High	Change from today's price
January, 2030	$55.52	$53.77	$56.88	+76.30%
February, 2030	$56.56	$55.44	$56.59	+79.63%
March, 2030	$57.51	$56.18	$58.49	+82.64%
April, 2030	$56.24	$55.15	$58.51	+78.61%
May, 2030	$55.04	$54.46	$57.56	+74.80%
June, 2030	$55.90	$54.47	$56.59	+77.53%
July, 2030	$56.58	$55.76	$58.31	+79.69%
August, 2030	$56.31	$55.29	$56.88	+78.83%
September, 2030	$54.23	$53.44	$56.79	+72.23%
October, 2030	$55.24	$54.21	$56.31	+75.43%
November, 2030	$57.80	$55.27	$57.99	+83.56%
December, 2030	$59.29	$57.73	$59.44	+88.29%

Similar to COGT